Krishna Institute of Medical Sciences Ltd.
KIMS · NSE · Healthcare
With a 20% margin of safety, our buy-below price is ₹285.51.
Piotroski F-score 3/9 — quality of earnings & balance sheet.
Investability checklist
- ✕ROE above 15%9.7%
- ✕Low debt (D/E < 0.5)1.66x
- ✕Positive free cash flow
- ✓Revenue growth > 10%35%
- ✕Earnings growing-58%
- ✕Net margin ≥ 10%6.2%
- ✕Current ratio > 1.50.76
- ✕Below our fair value
- ✕Margin of safety ≥ 20%
- ✓Above 200-day average
- ✓Above 50-day average
- –Positive 1-year return
- ✓Altman Z in safe zoneZ 4.2
- ✕Piotroski ≥ 73/9
1-year price
EOD · 2026-06-15Our scores
Key fundamentals
SWOT snapshot
Strengths
- •Financially solid — Altman Z 4.2.
Weaknesses
- •High debt relative to equity.
- •Weak Piotroski score (3/9).
Opportunities
- •Revenue growing (35% YoY).
Threats
- •Earnings contracting year on year.
- •Rich valuation versus sector peers.
- •Trades ~54% above our estimated fair value.
About Krishna Institute of Medical Sciences Ltd.
Krishna Institute of Medical Sciences Limited provides medical and health care services under the KIMS Hospitals brand in India. The company offers neurology, neurosurgery, psychiatry, and neuro rehabilitation; cardiology, cardiac and vascular surgery, heart transplant, and cardio rehabilitation; and pulmonology, interventional pulmonology, thoracic surgery, and lung transplant. It also provides medical and surgical gastroenterology, hepatobiliary pancreatic surgery, liver tr
More in Healthcare
Our verdict, fair value, financial-health and checklist are StocksWizard's own estimates, computed from public end-of-day data using standard models (DCF, relative valuation, Altman Z, Piotroski). For information only — not investment advice or a recommendation. Verify independently before investing.